{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T19:22:32Z","timestamp":1775848952233,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,7,13]],"date-time":"2013-07-13T00:00:00Z","timestamp":1373673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s10072-013-1496-4","type":"journal-article","created":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T10:43:20Z","timestamp":1373625800000},"page":"253-257","source":"Crossref","is-referenced-by-count":10,"title":["Atherogenic consequence of antiepileptic drugs: a study of intima-media thickness"],"prefix":"10.1007","volume":"35","author":[{"given":"Masoud","family":"Mehrpour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Shojaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safoora","family":"Gharibzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrshad","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,13]]},"reference":[{"issue":"4","key":"1496_CR1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11940-010-0080-y","volume":"12","author":"C Lopinto-Khoury","year":"2010","unstructured":"Lopinto-Khoury C, Mintzer S (2010) Antiepileptic drugs and markers of vascular risk. Curr Treat Options Neurol 12(4):300\u2013308","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"1496_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","volume":"54","author":"MJ Brodie","year":"2013","unstructured":"Brodie MJ, Mintzer S, Pack AM, Gidal BE, Vecht CJ, Schmidt D (2013) Enzyme induction with antiepileptic drugs: cause for concern? Epilepsia 54(1):11\u201327","journal-title":"Epilepsia"},{"issue":"9","key":"1496_CR3","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/pds.2186","volume":"20","author":"JB Olesen","year":"2011","unstructured":"Olesen JB, Abildstr\u00f8m SZ, Erdal J, Gislason GH, Weeke P, Andersson C, Torp-Pedersen C, Hansen PR (2011) Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study. Pharmacoepidemiol Drug Saf 20(9):964\u2013971","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6507","key":"1496_CR4","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/bmj.291.6507.1481","volume":"291","author":"A Muuronen","year":"1985","unstructured":"Muuronen A, Kaste M, Nikkil\u00e4 EA, Tolppanen EM (1985) Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study. Br Med J (Clin Res Ed) 291(6507):1481\u20131483","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"6","key":"1496_CR5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1528-1157.1984.tb03480.x","volume":"25","author":"JF Annegers","year":"1984","unstructured":"Annegers JF, Hauser WA, Shirts SB (1984) Heart disease mortality and morbidity in patients with epilepsy. Epilepsia 25(6):699\u2013704","journal-title":"Epilepsia"},{"issue":"10","key":"1496_CR6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.braindev.2008.11.001","volume":"31","author":"A Erdemir","year":"2009","unstructured":"Erdemir A, Cullu N, Yi\u015f U, Demircio\u011flu F, Kir M, Cakmak\u00e7i H, Unal N, Dirik E (2009) Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid. Brain Dev 31(10):713\u2013716","journal-title":"Brain Dev"},{"issue":"16","key":"1496_CR7","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2217\/pgs.12.163","volume":"13","author":"R Polimanti","year":"2012","unstructured":"Polimanti R, Piacentini S, Manfellotto D, Fuciarelli M (2012) Human genetic variation of CYP450 superfamily: analysis of functional diversity in worldwide populations. Pharmacogenomics 13(16):1951\u20131960","journal-title":"Pharmacogenomics"},{"key":"1496_CR8","doi-asserted-by":"crossref","unstructured":"Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M (2007) Mannheim carotid intima-media thickness consensus (2004\u20132006). An update on behalf of the advisory board of the 3rd and 4th watching the risk symposium, 13th and 15th European stroke conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 23(1):75\u201380","DOI":"10.1159\/000097034"},{"issue":"3","key":"1496_CR9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1734-1140(09)70082-9","volume":"61","author":"T Jakubus","year":"2009","unstructured":"Jakubus T, Michalska-Jakubus M, Lukawski K, Janowska A, Czuczwar SJ (2009) Atherosclerotic risk among children taking antiepileptic drugs. Pharmacol Rep 61(3):411\u2013423","journal-title":"Pharmacol Rep"},{"issue":"2","key":"1496_CR10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/pds.2073","volume":"20","author":"JB Olesen","year":"2011","unstructured":"Olesen JB, Hansen PR, Abildstr\u00f8m SZ, Andersson C, Weeke P, Schmiegelow M, Erdal J, Torp-Pedersen C, Gislason GH (2011) Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study. Pharmacoepidemiol Drug Saf 20(2):146\u2013153","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"1496_CR11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.braindev.2008.11.001","volume":"31","author":"A Erdemir","year":"2009","unstructured":"Erdemir A, Cullu N, Yi\u015f U, Demircio\u011flu F, Kir M, Cakmak\u00e7i H, Unal N, Dirik E (2009) Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid. Brain Dev 31(10):713\u2013716","journal-title":"Brain Dev"},{"issue":"2\u20133","key":"1496_CR12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2007.03.010","volume":"74","author":"SA Hamed","year":"2007","unstructured":"Hamed SA, Hamed EA, Hamdy R, Nabeshima T (2007) Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res 74(2\u20133):183\u2013192","journal-title":"Epilepsy Res"},{"issue":"1","key":"1496_CR13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1167.2011.03316.x","volume":"53","author":"YC Chuang","year":"2012","unstructured":"Chuang YC, Chuang HY, Lin TK, Chang CC, Lu CH, Chang WN, Chen SD, Tan TY, Huang CR, Chan SH (2012) Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia 53(1):120\u2013128","journal-title":"Epilepsia"},{"issue":"7","key":"1496_CR14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00381-012-1788-7","volume":"28","author":"H Tokgoz","year":"2012","unstructured":"Tokgoz H, Aydin K, Oran B, Kiyici A (2012) Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate. Childs Nerv Syst 28(7):1049\u20131053","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"1496_CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.braindev.2011.05.009","volume":"34","author":"U Yi\u015f","year":"2012","unstructured":"Yi\u015f U, Do\u011fan M (2012) Effects of oxcarbazepine treatment on serum lipids and carotid intima media thickness in children. Brain Dev 34(3):185\u2013188","journal-title":"Brain Dev"},{"issue":"11","key":"1496_CR16","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1177\/0883073808318538","volume":"23","author":"HY Tomoum","year":"2008","unstructured":"Tomoum HY, Awadallah MM, Fouad DA, Ali AH (2008) Lipid profile, apolipoproteins A and B in children with epilepsy. J Child Neurol 23(11):1275\u20131281","journal-title":"J Child Neurol"},{"issue":"6","key":"1496_CR17","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1528-1167.2009.02024.x","volume":"50","author":"TY Tan","year":"2009","unstructured":"Tan TY, Lu CH, Chuang HY, Lin TK, Liou CW, Chang WN, Chuang YC (2009) Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis. Epilepsia 50(6):1579\u20131586","journal-title":"Epilepsia"},{"issue":"2","key":"1496_CR18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yebeh.2004.11.013","volume":"6","author":"T Mahmoudian","year":"2005","unstructured":"Mahmoudian T, Iranpour R, Messri N (2005) Serum lipid levels during carbamazepine therapy in epileptic children. Epilepsy Behav 6(2):257\u2013259","journal-title":"Epilepsy Behav"},{"issue":"4","key":"1496_CR19","first-page":"217","volume":"101","author":"E Yilmaz","year":"2001","unstructured":"Yilmaz E, Do\u015fan Y, G\u00fcrg\u00f6ze MK, G\u00fcng\u00f6r S (2001) Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children. Acta Neurol Belg 101(4):217\u2013220","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"1496_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(00)00119-4","volume":"41","author":"J Eir\u00eds","year":"2000","unstructured":"Eir\u00eds J, Novo-Rodr\u00edguez MI, Del R\u00edo M, Meseguer P, Del R\u00edo MC, Castro-Gago M (2000) The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Res 41(1):1\u20137","journal-title":"Epilepsy Res"},{"issue":"5","key":"1496_CR21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/088307380101600511","volume":"16","author":"FM Aynaci","year":"2001","unstructured":"Aynaci FM, Orhan F, Orem A, Yildirmis S, Gedik Y (2001) Effect of Antiepileptic drugs on plasma lipoprotein (a) and other lipid levels in childhood. J Child Neurol 16(5):367\u2013369","journal-title":"J Child Neurol"},{"issue":"2","key":"1496_CR22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0387-7604(02)00163-8","volume":"25","author":"H Karabiber","year":"2003","unstructured":"Karabiber H, Sonmezgoz E, Ozerol E, Yakinci C, Otlu B, Yologlu S (2003) Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid. Brain Dev 25(2):113\u2013115","journal-title":"Brain Dev"},{"key":"1496_CR23","first-page":"48","volume":"199","author":"M Mania","year":"2011","unstructured":"Mania M, Javashvili L, Kasradze S, Okujava N (2011) Fasting insulin and HOMA-index changes in patients treated with valproic acid. Georgian Med News 199:48\u201352","journal-title":"Georgian Med News"},{"issue":"8","key":"1496_CR24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.seizure.2012.06.001","volume":"21","author":"J Fang","year":"2012","unstructured":"Fang J, Chen S, Tong N, Chen L, An D, Mu J, Zhou D (2012) Metabolic syndrome among Chinese obese patients with epilepsy on sodium valproate. Seizure 21(8):578\u2013582","journal-title":"Seizure"},{"issue":"5","key":"1496_CR25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1017\/S1047951110000697","volume":"20","author":"M Yildiz","year":"2010","unstructured":"Yildiz M, Simsek G, Uzun H, Uysal S, Sahin S, Balci H (2010) Assessment of low-density lipoprotein oxidation, paraoxonase activity, and arterial distensibility in epileptic children who were treated with anti-epileptic drugs. Cardiol Young 20(5):547\u2013554","journal-title":"Cardiol Young"},{"issue":"4","key":"1496_CR26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0404.1991.tb04691.x","volume":"83","author":"EP Calandre","year":"1991","unstructured":"Calandre EP, Rodriquez-Lopez C, Blazquez A, Cano D (1991) Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurol Scand 83(4):250\u2013253","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"1496_CR27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1528-1157.1992.tb02299.x","volume":"33","author":"EP Calandre","year":"1992","unstructured":"Calandre EP, Sinu\u00e9s Porta B, Garc\u00eda de la Calzada D (1992) The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients. Epilepsia 33(1):154\u2013157","journal-title":"Epilepsia"},{"key":"1496_CR28","doi-asserted-by":"crossref","unstructured":"Trocho C, Escol\u00e0-Gil JC, Ribas V, Ben\u00edtez S, Mart\u00edn-Campos JM, Rotllan N, Osaba L, Ord\u00f3\u00f1ez-Llanos J, Gonz\u00e1lez-Sastre F, Blanco-Vaca F (2004) Phenytoin treatment reduces atherosclerosis in mice through mechanisms independent of plasma HDL-cholesterol concentration. Atherosclerosis 174(2):275\u2013285","DOI":"10.1016\/j.atherosclerosis.2004.02.009"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-013-1496-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-013-1496-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-013-1496-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T17:00:15Z","timestamp":1646067615000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-013-1496-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,13]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1007\/s10072-013-1496-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,13]]}}}